Regression of melanoma in a murine model by RLIP76 depletion
2006

Inhibition of RLIP76 Causes Melanoma Regression in Mice

Sample size: 1 publication Evidence: high

Author Information

Author(s): Singhal SS, Awasthi YC, Awasthi S

Primary Institution: The University of Texas Medical Branch at Galveston

Hypothesis

Does the depletion of RLIP76 cause apoptosis in malignant melanoma cells?

Conclusion

Inhibition of RLIP76 leads to complete tumor regression in a mouse model of melanoma.

Supporting Evidence

  • Inhibition of RLIP76 causes apoptosis in malignant melanoma cells.
  • RLIP76 expression is greater in malignant cells than in nonmalignant cells.
  • A single dose of RLIP76 antibodies caused complete tumor regression in 10 days.

Takeaway

Scientists found that blocking a protein called RLIP76 can make melanoma tumors disappear in mice.

Methodology

The study involved comparing RLIP76 expression in normal and cancer cells and testing the effects of RLIP76 depletion on cancer cell apoptosis.

Limitations

Further studies are needed to confirm the applicability of these results to human clinical applications.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication